The commonly used tumor markers for the diagnosis and evaluation of CRC patients include carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), cancer antigen (CA)19 − 9 and alpha-fetoprotein (AFP) [21–24]. This evidence concerns the gene ENO2 and colorectal carcinoma.